Aspen API response to COVID-19 Latest update / 17 March 2022
Aspen concludes acquisition API business from from MSD
Oss, The Netherlands – JSE Limited listed Aspen Holdings, the ninth largest generic pharmaceutical company in the world, announced today that the Aspen Group (“Aspen”) has finalized the acquisition of Active Pharmaceutical Ingredients (API) manufacturing operations and related businesses (“the API business”) from MSD, known as Merck & Co., Inc. in the US and Canada. Stephen...
October 1, 201390 years of worldclass API production
Today is a special day for Aspen Oss, since our company was founded exactly 90 years ago. On July 9th 1923 we began our operations on API production by synthesis of insulin from animal tissue. Since 1923, we have transformed from a locally operating company to a multinational organization present in many countries worldwide selling our...
July 4, 2013CGMP certificate Moleneind & diosite
The Dutch Health Care Inspectorate has planned a next GMP inspection of our 2 API production locations in Oss-The Netherlands (Moleneind and Diosite) from November 19th to November 22nd 2013. As our current GMP certificate formally expired in June 2013, a formal Letter from our national health authorities was received to extend our current GMP status until the next inspection...
July 2, 2013Important announcement MSD/Aspen
On Thursday June 27th, 2013 MSD announced it signed a key agreement that marks a milestone in the negotiation of a transaction to sell the Oss API operations to South-African pharma company Aspen. The deal is expected to be finalized in the late third quarter or early fourth quarter of 2013 following the successful completion of...
June 27, 2013GDUFA regulation self identified sites registered apis
According to the GDUFA regulation in place for companies with registrations in the US, our API production sites in Oss/The Netherlands (De Geer/Veersemeer and Moleneind/Kloosterstraat) have been self-identified according to FDA requirements. The following APIs have been registered after the self-identification of our production sites: * Ethinyl estradiol * Estradiol micronized * Naltrexone * Norethindrone *...
January 7, 2013
